| 1 |
33563904 | Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. | 2021 Feb 1 |
1 |
| 2 |
32730663 | Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy. | 2020 Dec |
1 |
| 3 |
31203997 | Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia. | 2019 Jun |
2 |
| 4 |
31479709 | Modulation of FLT3 through decitabine-activated C/EBPa-PU.1 signal pathway in FLT3-ITD positive cells. | 2019 Dec |
7 |
| 5 |
28102729 | Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib. | 2017 Nov 2 |
2 |
| 6 |
26297284 | Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia. | 2015 Jun |
2 |
| 7 |
23798029 | Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia. | 2013 Dec |
1 |